Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Legal Names
Legal name
Similar Companies999
Vanqua Bio
Vanqua Bio is a biotech company that develops next-generation medicines for neurodegenerative diseases.
Sector
Subsector
Location
total rounds
total raised
Biomea Fusion
Biomea Fusion is a biopharmaceutical company developing covalent small molecules for cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
Synlogic
Synlogic is a biotechnology company that develops synthetic biotic medicines to treat diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Qlaris Bio
Qlaris Bio develops innovative therapies for serious eye diseases.
Sector
Subsector
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 10.10.2022. Their latest investor Lifeforce Capital. Their latest round Series A
Khosla Ventures
Khosla Ventures: venture capital firm advising entrepreneurs on breakthrough technologies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Co-Investors
Investors19
Number of lead investors
Number of investors
Lifeforce Capital
Lifeforce Capital is a venture capital firm that invests in digital health companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
EIT Health
EIT Health promotes entrepreneurship and innovates in healthy living and active ageing.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Khosla Ventures
Khosla Ventures: venture capital firm advising entrepreneurs on breakthrough technologies.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Nessan Bermingham
Nessan Bermingham is founder and CEO of Triplet Therapeutics, Inc. He is a serial biotech entrepreneur and investor who has founded several companies including Triplet, Korro Bio and Intellia Therapeutics, “one of the top 10 biotech start-ups in 2014” and a “Fierce 15 biotech company,” taking the company from concept to IPO and large partnering deals with approximately 200 employees. He has nearly two decades of experience in Life Sciences startups and investments, including small molecules, biologics, medical devices, and diagnostics through venture, public, and secondary markets. As a venture partner at Atlas Venture and managing partner at Omega Funds, he successfully invested in and managed multiple investments across the United States and Europe. Currently he is also a venture partner at Atlas Venture and is Chair of the Board of Directors of F-star and Akrevia Therapeutics. He served as Intellia’s President and CEO from inception until December 2017. Previously he was an independent advisory board member of the California Institute of Regenerative Medicine (CIRM) and MerckSerono KGaA. He received his Ph.D. in Molecular Biology from Imperial College London and was a Howard Hughes Associate Fellow at Baylor College of Medicine. He is an avid mountain biker, snowboarder and trail runner. Nessan is co-founder and was previously chief executive officer of Intellia Therapeutics. He led Intellia from seed investment and incubation at Atlas Venture through its IPO and the advancement of its gene editing platform toward clinical development. He has over ten years of experience in life science investing across venture, secondary, and public markets. Previously, Nessan was a partner at Omega Funds and founder of Bio Equity Capital, a healthcare focused special situations firm. Nessan is also co-founder of Tal Medical.
current job
organization founded
People
Founders2
Quin Wills
Quin is an MD and computational biologist. He founded his first liver drug company 15 years ago, co-steered Oxford's single-cell genomics consortium, and founded the Cellular and Systems Genomics department for a leading biopharma
current job
organization founded
Quin Wills
Jack O'meara
Jack is a biomedical engineer with background in bringing new health technologies to market. Jack helped get one of the first blockbuster gene therapies through FDA approval.
current job
organization founded
Jack O'meara
Employee Profiles2
Activity
Recent News5
The graph reveals the ratio (%) of positive news articles in a chosen time range